| Term 
 
        | Gastric acid is secreted by _______ cells |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | the proton pump is also called ______ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | adverse effects of H2-receptor antagonists |  | Definition 
 
        | diarrhoea, dizziness and muscle pain |  | 
        |  | 
        
        | Term 
 
        | How does cimetidine differ from other H2-receptor antagonists |  | Definition 
 
        | it is an inhibitor of CYP-450 |  | 
        |  | 
        
        | Term 
 
        | what are the four classes of drugs used in PUD and GORD |  | Definition 
 
        | antacids H2 receptor antagonists proton pump inhibitors muscarinic antagonists |  | 
        |  | 
        
        | Term 
 
        | are proton pump inhibitors reversibly or irreversibly bound to enzyme |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | side effects of long term use of PPI's |  | Definition 
 
        | hypochlorhydria and hypergastremia, which has lead to increase gastric tumours in animals |  | 
        |  | 
        
        | Term 
 
        | class and activity of Pirenzipine |  | Definition 
 
        | pirenzipine is a M1 receptor blocker, reduces secretion of gastric acids |  | 
        |  | 
        
        | Term 
 
        | what are the common side effects of Pirenzipine |  | Definition 
 
        | dry mouth and blurred vision |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
act by neutralizing acid and slightly increasing gastric pHrapid pain relief |  | 
        |  | 
        
        | Term 
 
        | adverse effect of magnesium hydroxide and magnesium trisilicate |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | adverse effect of aluminium hydroxide gel |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | side effects of  Calcium carbonate and Sodium bicarbonate |  | Definition 
 
        | 
 
generation of CO 2 (belching)  +  possible systemic side effects (metabolic alkalosis) |  | 
        |  | 
        
        | Term 
 
        | drugs for the protection of gastric mucosa |  | Definition 
 
        | bismuth chelate, misoprostal, sucralfate |  | 
        |  | 
        
        | Term 
 
        | key features of bismuth chelate |  | Definition 
 
        | 
–eradicating H.pylori in 30% of patients –coating the ulcer base –adsorbing pepsin and local PG synthesis |  | 
        |  | 
        
        | Term 
 
        | key features of misoprostal in GI |  | Definition 
 
        | 
–inhibits gastric acid secretion –maintains or increases mucosal blood flow –increases the secretion of mucus and bicarbonate |  | 
        |  | 
        
        | Term 
 
        | the two commonly used therapy for H.pylori erradication |  | Definition 
 
        | 
 
Triple Therapy: PPI+ Clarithromycin + amoxicillin/metronidazole   Quadruple Therapy: PPI + Bismuth + amoxicillin/metronidazole + tetracycline   |  | 
        |  | 
        
        | Term 
 
        | class and ADR of hyoscine |  | Definition 
 
        | anticholinergic anticholinergic SE + sedation |  | 
        |  |